Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hebbar

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Lupus|June 5, 2004
Antiphospholipid antibodies in primary Sjögren's syndrome: prevalence and clinical significance in a series of 74 patientsA L Fauchais, M Lambert, D Launay, et al.
Leukemia|February 3, 1998
Association between myelodysplastic syndromes and inflammatory bowel diseases. Report of seven new cases and review of the literatureM Hebbar, D Kozlowski, E Wattel, et al.
La Revue De Medecine Interne|October 16, 2001
[Pulmonary hypertension screening in systemic scleroderma: a cohort study of 67 patients]D Launay, E Hachulla, P Y Hatron, et al.
British Journal of Cancer|November 19, 2009
Quality-of-life findings from a randomised phase-III study of XELOX vs FOLFOX-6 in metastatic colorectal cancerT Conroy, M Hebbar, J Bennouna, et al.
La Revue De Medecine Interne|March 10, 2001
[Wegener's granulomatosis in the elderly patient]A L Fauchais, M Michon-Pasturel, C Rugale, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 7, 2012
Tumor size of hepatocellular carcinoma in noncirrhotic liver: a controversial predictive factor for outcome after resectionS Truant, E Boleslawski, A Duhamel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 13, 2006
Phase II study of an optimized 5-fluorouracil-oxaliplatin strategy (OPTIMOX2) with celecoxib in metastatic colorectal cancer: a GERCOR studyT André, C Tournigand, L Mineur, et al.
The Journal of Rheumatology|October 24, 2001
Aerosolized iloprost in CREST syndrome related pulmonary hypertensionD Launay, E Hachulla, P Y Hatron, et al.
Alimentary Pharmacology & Therapeutics|October 1, 2011
Safety and efficacy of sorafenib in hepatocellular carcinoma: the impact of the Child-Pugh scoreA Hollebecque, S Cattan, O Romano, et al.
Bulletin Du Cancer|January 7, 2005
[Standards, Options and Recommendations 2004: good practice guidelines for second opinion in anatomic and surgical pathology in oncology (integral report)]J Hassoun, Anne Bataillard, Jean-Jacques Voigt, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Lupus|June 5, 2004
Antiphospholipid antibodies in primary Sjögren's syndrome: prevalence and clinical significance in a series of 74 patientsA L Fauchais, M Lambert, D Launay, et al.
Leukemia|February 3, 1998
Association between myelodysplastic syndromes and inflammatory bowel diseases. Report of seven new cases and review of the literatureM Hebbar, D Kozlowski, E Wattel, et al.
La Revue De Medecine Interne|October 16, 2001
[Pulmonary hypertension screening in systemic scleroderma: a cohort study of 67 patients]D Launay, E Hachulla, P Y Hatron, et al.
British Journal of Cancer|November 19, 2009
Quality-of-life findings from a randomised phase-III study of XELOX vs FOLFOX-6 in metastatic colorectal cancerT Conroy, M Hebbar, J Bennouna, et al.
La Revue De Medecine Interne|March 10, 2001
[Wegener's granulomatosis in the elderly patient]A L Fauchais, M Michon-Pasturel, C Rugale, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 7, 2012
Tumor size of hepatocellular carcinoma in noncirrhotic liver: a controversial predictive factor for outcome after resectionS Truant, E Boleslawski, A Duhamel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 13, 2006
Phase II study of an optimized 5-fluorouracil-oxaliplatin strategy (OPTIMOX2) with celecoxib in metastatic colorectal cancer: a GERCOR studyT André, C Tournigand, L Mineur, et al.
The Journal of Rheumatology|October 24, 2001
Aerosolized iloprost in CREST syndrome related pulmonary hypertensionD Launay, E Hachulla, P Y Hatron, et al.
Alimentary Pharmacology & Therapeutics|October 1, 2011
Safety and efficacy of sorafenib in hepatocellular carcinoma: the impact of the Child-Pugh scoreA Hollebecque, S Cattan, O Romano, et al.
Bulletin Du Cancer|January 7, 2005
[Standards, Options and Recommendations 2004: good practice guidelines for second opinion in anatomic and surgical pathology in oncology (integral report)]J Hassoun, Anne Bataillard, Jean-Jacques Voigt, et al.
Pageof 8